Bioneex
PrivateLast Round
Seed
Feb 15, 2024
Total Funding Raised
$500,000
Company Overview
Bioneex is a healthcare services company that operates an AI-powered platform connecting drug development companies with biopharma partners and venture capital investors for licensing, partnerships, and investments.
Sector
Enterprise Software
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Subscription SaaS, Marketplace Commission, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bioneex Comparables
Compare Bioneex with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Clarivate Plc | 69% | |
| Norstella | 64% | |
| Techspert | 60% | |
Bioneex Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 15, 2024 | ||||
| VC Round | Feb 15, 2024 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 1, 2026
Monthly visitors increased 50% MoM.
- Nov 7, 2025
Monthly visitors increased 52% MoM, reaching 1.2K.
Bioneex Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Bioneex's valuation, stock price, and market status.